Zobrazeno 1 - 10 of 37 pro vyhledávání: '"Ap, Lacerda"'
1
Malignant Boutonneuse fever with multiple organ failure: a three-case series
Autor: Carlos França, B Oliveira, Z Costa e Silva, AP Lacerda
Publikováno v: Critical Care
Rickettsia conorii infection, the agent of Boutonneuse fever, presents usually in a form considered benign, with serious complications in less than 10% of patients. Its mechanism of infection consists of vascular endothelial invasion by the microorga
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64e3f12c6a8ed0f4fe64e933afe08311
https://doi.org/10.1186/cc7478
Zobrazit plný text záznamu
2
[Incessant atrial tachycardia and peripartum cardiomyopathy--a therapeutic challenge]
Autor: Dulce Brito, Ap, Lacerda, Freitas P, Costa e Silva Z, Bento H, de Sousa J, Fiuza M, Mg, Lopes, Barbosa M, França C
Publikováno v: Europe PubMed Central
CIÊNCIAVITAE
Peripartum cardiomyopathy is an uncommon cause of heart failure but with serious prognosis. We report the case of a patient with peripartum cardiomyopathy presenting acute heart failure (severe biventricular systolic failure) and incessant atrial tac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b23f07819ded18951b792ffc2aebacdf
http://europepmc.org/abstract/med/9138464
Zobrazit plný text záznamu
4
Akademický článek
Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn's Disease.
Autor: Ghosh S; College of Medicine and Health and APC Microbiome Ireland, University College Cork, Cork, Ireland., Feagan BG; Robarts Research Institute, Western University, London, ON, Canada.; Alimentiv Inc., London, ON, Canada., Parra RS; Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil., Lopes S; Centro Hospitalar e Universitário São João, Porto, Portugal., Steinlauf A; IBD Clinical Center, Mount Sinai Hospital, New York, NY, USA., Kakuta Y; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan., Joshi N; Health Economics & Outcomes Research, AbbVie Inc., North Chicago, IL, USA., Lee WJ; Health Economics & Outcomes Research, AbbVie Inc., North Chicago, IL, USA., Lacerda AP; Health Economics & Outcomes Research, AbbVie Inc., North Chicago, IL, USA., Zhou Q; Health Economics & Outcomes Research, AbbVie Inc., North Chicago, IL, USA., Xuan S; Health Economics & Outcomes Research, AbbVie Inc., North Chicago, IL, USA., Kligys K; Health Economics & Outcomes Research, AbbVie Inc., North Chicago, IL, USA., Shukla N; Health Economics & Outcomes Research, AbbVie Inc., North Chicago, IL, USA., Louis E; Department of Gastroenterology, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Nov 04; Vol. 18 (11), pp. 1804-1818.
Zobrazit plný text záznamu
5
Akademický článek
Pharmacokinetics and Exposure-Response Analyses to Support Dose Selection of Upadacitinib in Crohn's Disease.
Autor: Bhatnagar S; Clinical Pharmacology, AbbVie, North Chicago, Illinois, USA., Schlachter L; Clinical Pharmacology, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany., Eckert D; Clinical Pharmacology, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany., Stodtmann S; Clinical Pharmacology, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany., Liu W; Clinical Pharmacology, AbbVie, North Chicago, Illinois, USA., Lacerda AP; Immunology Clinical Development, AbbVie, North Chicago, Illinois, USA., Mohamed MF; Clinical Pharmacology, AbbVie, North Chicago, Illinois, USA.
Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Nov; Vol. 116 (5), pp. 1240-1251. Date of Electronic Publication: 2024 Jul 09.
Zobrazit plný text záznamu
6
Akademický článek
Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports.
Autor: Mahadevan U; Division of Gastroenterology and Hepatology, University of California San Francisco, 1701 Divisadero Street #120, San Francisco, CA, 94010, USA. Uma.mahadevan@ucsf.edu., Levy G; AbbVie, Inc., Chicago, IL, USA., Gensler L; Division of Rheumatology, University of California San Francisco, San Francisco, CA, USA., Ali M; AbbVie, Inc., Chicago, IL, USA., Lacerda AP; AbbVie, Inc., Chicago, IL, USA., Wegrzyn L; AbbVie, Inc., Chicago, IL, USA., Palac H; AbbVie, Inc., Chicago, IL, USA., Bhutani-Jacques T; Division of Rheumatology, University of California San Francisco, San Francisco, CA, USA., Long M; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Clowse MEB; Division of Rheumatology and Immunology, Duke University, Durham, NC, USA., Kimball AB; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Chambers C; Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA., Scialli AR; Scialli Consulting LLC, Washington, DC, USA.
Publikováno v: Drug safety [Drug Saf] 2024 Oct; Vol. 47 (10), pp. 1039-1049. Date of Electronic Publication: 2024 Jul 15.
Zobrazit plný text záznamu
7
Akademický článek
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure.
Autor: Peyrin-Biroulet L; Department of Gastroenterology, Nancy University Hospital, Vandœuvre-lès-Nancy, France; INSERM, NGERE, University of Lorraine, Nancy, France; INFINY Institute, Nancy University Hospital, Vandœuvre-lès-Nancy, France; FHU-CURE, Nancy University Hospital, Vandœuvre-lès-Nancy, France; Groupe Hospitalier Privé Ambroise Paré - Hartmann, Paris IBD Center, Neuilly-sur-Seine, France. Electronic address: consultinglpb@gmail.com., Panaccione R; Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Louis E; Hepato-Gastroenterology and Digestive Oncology Department, University Hospital CHU of Liège, Liège, Belgium., Atreya R; First Department of Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany., Rubin DT; Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, Illinois., Lindsay JO; Centre for Immunobiology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Siffledeen J; Division of Gastroenterology, Covenant Health Grey Nuns Community Hospital, Edmonton, Alberta, Canada., Lukin DJ; Department of Gastroenterology and Hepatology, New York Presbyterian/Weill Cornell Medical Center, New York, New York., Wright J; Kingsbury Hospital, Cape Town, South Africa., Watanabe K; Department of Internal Medicine for Inflammatory Bowel Disease, University of Toyama, Toyama, Japan., Ford S; AbbVie Inc, North Chicago, Illinois., Remple VP; AbbVie Inc, North Chicago, Illinois., Lacerda AP; AbbVie Inc, North Chicago, Illinois., Dubcenco E; AbbVie Inc, North Chicago, Illinois., Garrison A; AbbVie Inc, North Chicago, Illinois., Zhou Q; AbbVie Inc, North Chicago, Illinois., Berg S; AbbVie Inc, North Chicago, Illinois., Anyanwu SI; AbbVie Inc, North Chicago, Illinois., Schreiber S; Department Internal Medicine, University Hospital Schleswig-Holstein, Christian Albrechts University, Kiel, Germany.
Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2024 Oct; Vol. 22 (10), pp. 2096-2106. Date of Electronic Publication: 2024 Mar 15.
Zobrazit plný text záznamu
8
Akademický článek
Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn's Disease: A Post Hoc Analysis of 3 Phase 3 Trials.
Autor: Colombel JF; Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: jean-frederic.colombel@mssm.edu., Lacerda AP; AbbVie Inc., North Chicago, Illinois., Irving PM; IBD Centre, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Panaccione R; Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada., Reinisch W; Department of Internal Medicine, Medical University of Vienna, Vienna, Austria., Rieder F; Department of Gastroenterology, Hepatology, and Nutrition, Digestive Diseases Institute, Cleveland Clinic, Cleveland, Ohio., Steinlauf A; Department of Gastroenterology, Mount Sinai Hospital, New York, New York., Schwartz D; Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee., Feng T; AbbVie Inc., North Chicago, Illinois., Dubcenco E; AbbVie Inc., North Chicago, Illinois., Anyanwu SI; AbbVie Inc., North Chicago, Illinois., Laroux FS; AbbVie Bioresearch Center, Worcester, Massachusetts., Cunneen C; AbbVie Inc., North Chicago, Illinois., Powell N; Division of Digestive Diseases, Imperial College London, London, United Kingdom.
Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2024 Sep 24. Date of Electronic Publication: 2024 Sep 24.
Zobrazit plný text záznamu
9
Akademický článek
Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn's Disease.
Autor: Panés J; Hospital Clínic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain., Louis E; Department of Clinical Sciences, University Hospital CHU of Liège, Liège, Belgium., Bossuyt P; Imelda Gastrointestinal (GI) Clinical Research Center, Imelda General Hospital, Bonheiden, Belgium., Joshi N; HEOR, AbbVie Inc., North Chicago, IL, USA., Lee WJ; HEOR, AbbVie Inc., North Chicago, IL, USA., Lacerda AP; HEOR, AbbVie Inc., North Chicago, IL, USA., Kligys K; HEOR, AbbVie Inc., North Chicago, IL, USA., Xuan S; HEOR, AbbVie Inc., North Chicago, IL, USA., Shukla N; HEOR, AbbVie Inc., North Chicago, IL, USA., Loftus EV Jr; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Publikováno v: Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Sep 04. Date of Electronic Publication: 2024 Sep 04.
Zobrazit plný text záznamu
10
Akademický článek
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease.
Autor: Louis E; University of Liège, Liège, Belgium. Edouard.Louis@ulg.ac.be., Lee WJ; AbbVie Inc, Chicago, IL, USA., Litcher-Kelly L; Adelphi Values, Boston, MA, USA., Ollis S; Adelphi Values, Boston, MA, USA., Pranschke E; Adelphi Values, Boston, MA, USA., Fitzgerald K; AbbVie Inc, Chicago, IL, USA., Lacerda AP; AbbVie Inc, Chicago, IL, USA., Neimark E; AbbVie Inc, Chicago, IL, USA., Sanchez Gonzalez Y; AbbVie Inc, Chicago, IL, USA., Panés J; Hospital Clínic de Barcelona, Barcelona, Spain.
Publikováno v: Advances in therapy [Adv Ther] 2024 Sep; Vol. 41 (9), pp. 3678-3705. Date of Electronic Publication: 2024 Aug 06.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje